↓ Skip to main content

Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review

Overview of attention for article published in CNS Drugs, November 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#17 of 1,401)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
16 news outlets
blogs
3 blogs
policy
2 policy sources
twitter
11 X users
wikipedia
1 Wikipedia page
video
4 YouTube creators

Citations

dimensions_citation
98 Dimensions

Readers on

mendeley
178 Mendeley
Title
Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review
Published in
CNS Drugs, November 2019
DOI 10.1007/s40263-019-00680-w
Pubmed ID
Authors

Frank M. C. Besag, Michael J. Vasey, Kim S. J. Lao, Ian C. K. Wong

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 178 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 11%
Researcher 18 10%
Student > Ph. D. Student 12 7%
Other 11 6%
Student > Postgraduate 10 6%
Other 28 16%
Unknown 80 45%
Readers by discipline Count As %
Medicine and Dentistry 35 20%
Biochemistry, Genetics and Molecular Biology 8 4%
Nursing and Health Professions 8 4%
Psychology 8 4%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Other 27 15%
Unknown 84 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 158. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2024.
All research outputs
#264,710
of 25,779,988 outputs
Outputs from CNS Drugs
#17
of 1,401 outputs
Outputs of similar age
#5,603
of 376,411 outputs
Outputs of similar age from CNS Drugs
#1
of 20 outputs
Altmetric has tracked 25,779,988 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,401 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 376,411 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.